C-LINE™ Anti-Microbial

TO IMPROVE THE ANTI-MICROBIAL EFFECT OF THE CVC, EXTEND THE IMPLANTATION DURATION OF CATHETERS IN THE HUMAN BODY. UMBRA MEDICAL'S R&D SPECIALISTS UTILIZED THE PROLONGED DRUG RELEASE TECHNOLOGY OF COATING THE CATHETER AND SUCCESSFULLY DEVELOPED ANTI-MICROBIAL CVC. MOLECULAR LEVEL OF MINOCYCLINE AND RIFAMPICIN IS INFILTRATEDON BOTH INTERNAL AND EXTERNAL WALL OF CATHETER AND RELEASED GRADUALLY AFTER IMPLANTATION. DURABLE AND RELIABLE ANTIBACTERIAL EFFECT GUARANTEES SUCCESSFUL PREVENTION OF CRBSI.
DESCRIPTION OF COATING: RIFAMPICIN (C43H58N4012) MINOCYCLINE (C23H27N307)
FUNCTION: REDUCE THE RISK OF INFECTION AND EXTEND THE IMPLANTATION DURATION OF CATHETERS IN THE HUMAN BODY.